Mergers & Acquisitions 

Dear Clients and Friends, Following the guidelines issued by the Tax Authority in 2023, which expired on December 31, 2024 (See our previous update in this regard), the Tax Authority published new guidelines on January 29, 2025. These guidelines will apply to the taxation of investments through SAFE (Simple Agreement for Future Equity) in Israeli […]

We are honored to have taken an active part in the 9th conference of the International Bar Association held in Washington, focused on health and life sciences. Gary Copelovitz, who co-heads our Technology and M&A department, and heads our vibrant Life Sciences practice, moderated a round table on the new heavyweight players in the healthcare […]

On May 16, 2023, the Israeli Tax Authority issued guidance regarding the taxation of investments in companies through Simple Agreement for Future Equity (i.e., SAFE). SAFE instrument was introduced as an alternative to traditional investment or convertible loan for early-stage investments in startups. SAFEs offer simplicity, efficiency and cost-effectiveness and enable the startup companies to […]

Gali Opinsky, Partner and Head of the Intellectual Property Practice and Gary Copelovitz, Partner and co-Head of the Technology. Corporate. M&A Department in our firm, recognized by the World Trademark Review (WTR) as a recommended expert lawyers in Israel, as well as specific recognition in trademark law enforcement and litigation, transactions and prosecution and strategy. […]

Desert Tech: Dr. Ziv Preis, co-head of the firm’s Technology, Corporate and M&A Department, together with Adv. Natalie Shva, have explored the investment opportunities in Desert Tech in an article in The US-Israel Legal Review. Read the full article

 Read an article on A Year of Crisis in Israeli High Tech as an Opportunity for Better Future, which was written by Dr. Ziv Preis, partner and co-head of our Technology. Corporate, and Mergers & Acquisitions Department. The article addresses the strength of the Israeli high-tech, the challenges and the call for opportunity. The full […]

It was a privilege to contribute to a national exploration of trends affecting the Israeli life sciences sector, carried out by Israel Desks magazine. “Med-tech is here to stay,” pointed out Gary Copelovitz, partner and co-head of our Technology, Corporate and M&A Department, also stating that VC funds are “looking to continue challenging and disrupting […]

As an international organization comprising more than 70 law firms worldwide, Ally Law has worked with its member firms to put together a valuable guide on the regulation of e-signatures and digital transactions around the world. Gary Copelovitz, Head of our International Department, provided the relevant information on the applicable regulation in Israel, which you […]

What can we expect from Israel’s new government? “In the last decade, the Israeli high-tech ecosystem has grown from the Startup Nation to the Scale-Up Nation,” stated Dr. Preis from Lipa, Meir & Co. Law Firm. “The new government should embrace the desire of Israeli high-tech entrepreneurs to switch from ‘exit culture’ to ‘building Israeli […]

For the first time, an Israeli technological group in the artificial intelligence field has lead and established a pioneering venture for managing the water infrastructure system in the country – In Israel. Dr. Ziv Preis Preis and Tom Nissani of our Cross Border Mergers & Acquisitions, Banking & Finance Department represented Evolution Water, an artificial intelligence company, […]

Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment […]

Mileutis is in advanced stages of development of an innovative product which addresses bovine mastitis, the main concern in the dairy industry. Israeli animal health company Mileutis Ltd. has received a $20 million investment from US life sciences and healthcare investor NovaQuest Capital Management LLC, as part of a product financing agreement. Ness Ziona-based Mileutis […]

Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]

A common closing condition in M&A agreements is that there has been no material adverse change (MAC clause), or material adverse effect (MAE clause) with respect to the target company and its business, from the date of signing the agreement until the closing of the transaction. In this article, we address whether the COVID 19 epidemic could be […]

Many mergers and acquisitions, including investments, have a time period between signing the transaction agreement and closing the transaction. Several factors may lead to that time period such as the need to obtain regulatory approvals (e.g., Competition Authority, the Israeli Lands Authority) to complete the transaction or to obtain the approval of the target company’s […]

An employee exercising options to company’s shares is not necessarily a shareholder with shareholders rights as long as those shares are held by the trustee According to a recent decision in the Haifa District Court – Civil Case 19042-03-18 Navon vs. Sol Chip Ltd. – an employee has been granted options to purchase shares of […]

We are proud to announce the acquisition of the Israeli start-up, AMS Technologies, by Newater, a Chinese public company traded on the NASDAQ. Both companies are engaged in the field of wastewater technologies. AMS was represented by Adv. Gary Copelovitz, Danit Rimon and Gad Keren of our firm.  For the full article in Calcalist, click here